跳至主要内容
临床试验/NCT00804219
NCT00804219已完成4 期

Characterization of Humoral and Cellular Immunity of Low and High-responders After TBE Vaccination

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
67
试验地点
2
主要终点
cellular TBE immunity (cytokine production) 7 days after TBE-booster plus influenza vaccination

研究概览

简要总结

The phenomenon of no- and low-responsiveness has been described after applications of different vaccines (e.g. hepatitis B, TBE) and is concerning about 2-10% of the vaccinees.

The aim of this project is to investigate the humoral and cellular immune responses of low-responders after TBE vaccination in order to find parameters regarding immunoregulation against TBE. It is of interest if non-responsiveness is a general immunological deficit of a distinct patient group or if it is a antigen-specific phenomenon.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥18 years) of both sexes without upper age limit
  • Willingness to sign written informed consent form
  • Basic vaccination plus one booster (minimum) of TBE-vaccine,

排除标准

  • Age: < 18 years
  • Pregnancy or breast feeding
  • Prior TBE infection
  • Planned surgery within 2 weeks before/after any scheduled rabies vaccination during the entire study
  • Concomitant medication: systemic cortisone, immune suppressive therapy 4 weeks before or planned medication during the study
  • History of autoimmune disease
  • Drug addiction
  • Plasma donators
  • Administration of other vaccines 4 weeks before/after day 0
  • Administration of immunoglobulins 6 weeks prior to any vaccination or blood donation during the entire study period
  • Specific Immune Therapy (Hypo-/Desensibilization) within 14 days before and after the 2 study vaccination doses.
  • History of any malignant disease 5 years prior to the study entry
  • Any contraindication for the administration of the TBE- or influenza vaccine according to the manufactures information.

结局指标

主要结局

cellular TBE immunity (cytokine production) 7 days after TBE-booster plus influenza vaccination

时间窗: 7 days after TBE-booster plus influenza vaccination

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验